Visiopharm is a technology company specializing in digital pathology solutions. The company focuses on developing software that enhances the analysis and interpretation of histopathological images, enabling pathologists and researchers to improve diagnostic accuracy and efficiency. Visiopharm's platform integrates advanced image analysis, machine learning, and artificial intelligence to support various applications in clinical and research settings. Their solutions are designed to facilitate quantitative assessment of tissue samples, streamline workflows, and enhance collaboration among healthcare professionals.